171 related articles for article (PubMed ID: 38698266)
41. A colon cancer-derived mutant of Krüppel-like factor 5 (KLF5) is resistant to degradation by glycogen synthase kinase 3β (GSK3β) and the E3 ubiquitin ligase F-box and WD repeat domain-containing 7α (FBW7α).
Bialkowska AB; Liu Y; Nandan MO; Yang VW
J Biol Chem; 2014 Feb; 289(9):5997-6005. PubMed ID: 24398687
[TBL] [Abstract][Full Text] [Related]
42. Ampelopsin induces apoptosis by regulating multiple c-Myc/S-phase kinase-associated protein 2/F-box and WD repeat-containing protein 7/histone deacetylase 2 pathways in human lung adenocarcinoma cells.
Chen XM; Xie XB; Zhao Q; Wang F; Bai Y; Yin JQ; Jiang H; Xie XL; Jia Q; Huang G
Mol Med Rep; 2015 Jan; 11(1):105-12. PubMed ID: 25333250
[TBL] [Abstract][Full Text] [Related]
43. Wogonin has multiple anti-cancer effects by regulating c-Myc/SKP2/Fbw7α and HDAC1/HDAC2 pathways and inducing apoptosis in human lung adenocarcinoma cell line A549.
Chen XM; Bai Y; Zhong YJ; Xie XL; Long HW; Yang YY; Wu SG; Jia Q; Wang XH
PLoS One; 2013; 8(11):e79201. PubMed ID: 24265759
[TBL] [Abstract][Full Text] [Related]
44. The F-box protein FBXL16 up-regulates the stability of C-MYC oncoprotein by antagonizing the activity of the F-box protein FBW7.
Morel M; Shah KN; Long W
J Biol Chem; 2020 Jun; 295(23):7970-7980. PubMed ID: 32345600
[TBL] [Abstract][Full Text] [Related]
45. Pten regulates Aurora-A and cooperates with Fbxw7 in modulating radiation-induced tumor development.
Kwon YW; Kim IJ; Wu D; Lu J; Stock WA; Liu Y; Huang Y; Kang HC; DelRosario R; Jen KY; Perez-Losada J; Wei G; Balmain A; Mao JH
Mol Cancer Res; 2012 Jun; 10(6):834-44. PubMed ID: 22513362
[TBL] [Abstract][Full Text] [Related]
46. Increased efficiency in the generation of induced pluripotent stem cells by Fbxw7 ablation.
Okita Y; Matsumoto A; Yumimoto K; Isoshita R; Nakayama KI
Genes Cells; 2012 Sep; 17(9):768-77. PubMed ID: 22897623
[TBL] [Abstract][Full Text] [Related]
47. Mechanisms of c-myc degradation by nickel compounds and hypoxia.
Li Q; Kluz T; Sun H; Costa M
PLoS One; 2009 Dec; 4(12):e8531. PubMed ID: 20046830
[TBL] [Abstract][Full Text] [Related]
48. Regulation of GSK3β-FBXW7-JUNB axis.
Pérez-Benavente B; Farràs R
Oncotarget; 2013 Jul; 4(7):956-7. PubMed ID: 23918007
[No Abstract] [Full Text] [Related]
49. MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7.
Xu Y; Sengupta T; Kukreja L; Minella AC
J Biol Chem; 2010 Nov; 285(45):34439-46. PubMed ID: 20826802
[TBL] [Abstract][Full Text] [Related]
50. SCF(FBXW7)-mediated degradation of p53 promotes cell recovery after UV-induced DNA damage.
Galindo-Moreno M; Giráldez S; Limón-Mortés MC; Belmonte-Fernández A; Reed SI; Sáez C; Japón MÁ; Tortolero M; Romero F
FASEB J; 2019 Oct; 33(10):11420-11430. PubMed ID: 31337255
[TBL] [Abstract][Full Text] [Related]
51. FBXW7/hCDC4 is a general tumor suppressor in human cancer.
Akhoondi S; Sun D; von der Lehr N; Apostolidou S; Klotz K; Maljukova A; Cepeda D; Fiegl H; Dafou D; Marth C; Mueller-Holzner E; Corcoran M; Dagnell M; Nejad SZ; Nayer BN; Zali MR; Hansson J; Egyhazi S; Petersson F; Sangfelt P; Nordgren H; Grander D; Reed SI; Widschwendter M; Sangfelt O; Spruck C
Cancer Res; 2007 Oct; 67(19):9006-12. PubMed ID: 17909001
[TBL] [Abstract][Full Text] [Related]
52. Copy number loss of FBXW7 is related to gene expression and poor prognosis in esophageal squamous cell carcinoma.
Yokobori T; Mimori K; Iwatsuki M; Ishii H; Tanaka F; Sato T; Toh H; Sudo T; Iwaya T; Tanaka Y; Onoyama I; Kuwano H; Nakayama KI; Mori M
Int J Oncol; 2012 Jul; 41(1):253-9. PubMed ID: 22576686
[TBL] [Abstract][Full Text] [Related]
53. Coordination-driven FBXW7 DNAzyme-Fe nanoassembly enables a binary switch of breast cancer cell cycle checkpoint responses for enhanced ferroptosis-radiotherapy.
Yu J; Zhang Y; Li L; Xiang Y; Yao X; Zhao Y; Cai K; Li M; Li Z; Luo Z
Acta Biomater; 2023 Oct; 169():434-450. PubMed ID: 37516418
[TBL] [Abstract][Full Text] [Related]
54. The Role of FBXW7 in Gynecologic Malignancies.
Di Fiore R; Suleiman S; Drago-Ferrante R; Subbannayya Y; Suleiman S; Vasileva-Slaveva M; Yordanov A; Pentimalli F; Giordano A; Calleja-Agius J
Cells; 2023 May; 12(10):. PubMed ID: 37408248
[TBL] [Abstract][Full Text] [Related]
55. Loss of FBXW7-mediated degradation of BRAF elicits resistance to BET inhibitors in adult T cell leukemia cells.
Yeh CH; Bellon M; Wang F; Zhang H; Fu L; Nicot C
Mol Cancer; 2020 Sep; 19(1):139. PubMed ID: 32907612
[TBL] [Abstract][Full Text] [Related]
56. Distinct Interactions of EBP1 Isoforms with FBXW7 Elicits Different Functions in Cancer.
Wang Y; Zhang P; Wang Y; Zhan P; Liu C; Mao JH; Wei G
Cancer Res; 2017 Apr; 77(8):1983-1996. PubMed ID: 28209614
[TBL] [Abstract][Full Text] [Related]
57. Regulation mechanism of Fbxw7-related signaling pathways (Review).
Zhou Z; He C; Wang J
Oncol Rep; 2015 Nov; 34(5):2215-24. PubMed ID: 26324296
[TBL] [Abstract][Full Text] [Related]
58. A widely used pan-isoform-FBXW7 antibody used in cell cycle studies does not detect FBXW7.
Ennis H; McDonald DM
Cell Cycle; 2023 Jun; 22(11):1380-1390. PubMed ID: 37183425
[TBL] [Abstract][Full Text] [Related]
59. Loss of Fbxw7 triggers mammary tumorigenesis associated with E2F/c-Myc activation and Trp53 mutation.
Meyer AE; Furumo Q; Stelloh C; Minella AC; Rao S
Neoplasia; 2020 Nov; 22(11):644-658. PubMed ID: 33070870
[TBL] [Abstract][Full Text] [Related]
60. Degradation of the endoplasmic reticulum-anchored transcription factor MyRF by the ubiquitin ligase SCF
Nakayama S; Yumimoto K; Kawamura A; Nakayama KI
J Biol Chem; 2018 Apr; 293(15):5705-5714. PubMed ID: 29472293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
